DJ Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ rose 2.35% to $24.84 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.51% to 17,977.73 and the Dow Jones Industrial Average rising 1.39% to 41,317.43.
Catalyst Pharmaceuticals Inc. closed 5.04% below its 52-week high of $26.16, which the company reached on March 24th.
The stock outperformed some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 1.07% to $156.12, Pfizer Inc. $(PFE)$ rose 1.13% to $24.20, and Abbott Laboratories $(ABT)$ rose 1.48% to $132.82.
Trading volume (764,323) remained 571,199 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 2, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 02, 2025 17:22 ET (21:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。